STERIS plc (Ireland) Ordinary Shares (STE): Price and Financial Metrics

STERIS plc (Ireland) Ordinary Shares (STE)

Today's Latest Price: $184.96 USD

1.46 (-0.78%)

Updated Oct 27 1:20pm

Add STE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

STE Stock Summary

  • STERIS plc's market capitalization of $15,855,599,461 is ahead of 88.72% of US-listed equities.
  • The price/operating cash flow metric for STERIS plc is higher than 84.1% of stocks in our set with a positive cash flow.
  • The volatility of STERIS plc's share price is greater than that of merely 6.81% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to STERIS plc, a group of peers worth examining would be SNN, COO, PNR, BRO, and CSL.
  • Visit STE's SEC page to see the company's official filings. To visit the company's web site, go to

STE Stock Price Chart Interactive Chart >

Price chart for STE

STE Price/Volume Stats

Current price $184.96 52-week high $192.97
Prev. close $186.42 52-week low $105.69
Day low $184.84 Volume 96,673
Day high $188.01 Avg. volume 590,835
50-day MA $171.59 Dividend yield 0.86%
200-day MA $157.02 Market Cap 15.73B

STERIS plc (Ireland) Ordinary Shares (STE) Company Bio

Steris Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The company was founded in 1985 and is based in Mentor, Ohio.

STE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$184.96$134.5 -28%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for STERIS plc. To summarize, we found that STERIS plc ranked in the 39th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 27.5%. In terms of the factors that were most noteworthy in this DCF analysis for STE, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 13.87; that's higher than 77.47% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than just 18.27% of the free cash flow producing stocks we're observing.
  • STE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 40.92% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ICLR, EBS, CNC, PAHC, and BDX can be thought of as valuation peers to STE, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

STE Latest News Stream

Event/Time News Detail
Loading, please wait...

STE Latest Social Stream

Loading social stream, please wait...

View Full STE Social Stream

Latest STE News From Around the Web

Below are the latest news stories about STERIS plc that investors may wish to consider to help them evaluate STE as an investment opportunity.

Global Medical Device Cleaning Industry 2020-2025 with STERIS, Getinge Group, Cantel Medical, Ecolab, and The 3M Company Dominating -


Business Wire | August 6, 2020

STERIS Announces Financial Results for Fiscal 2021 First Quarter

• First quarter revenue declines low-single digits due to reduction in deferrable procedures• First quarter net income grows low-single…

GlobeNewswire | August 3, 2020

Earnings Preview: Steris

Steris (NYSE: STE) unveils its next round of earnings this Monday, August 03. Get prepared with Benzinga's ultimate preview for Steris's Q1 …

Benzinga | July 31, 2020

Analysts Estimate Steris (STE) to Report a Decline in Earnings: What to Look Out for

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2020

STERIS to Host a Conference Call for Fiscal 2021 First Quarter Financial Results on August 4, 2020

DUBLIN, IRELAND, July 22, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 4, 2020.  The conference call can be heard live over the Internet at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  A press release detailing first quarter financial results will be issued after the U.S. market closes on Monday, August 3, 2020. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. Eastern Time on August 4, 2020, either over the Internet at ww...

Yahoo | July 22, 2020

Read More 'STE' Stories Here

STE Price Returns

1-mo 8.67%
3-mo 14.66%
6-mo 30.44%
1-year 33.90%
3-year 105.98%
5-year 180.51%
YTD 22.22%
2019 44.09%
2018 23.66%
2017 31.73%
2016 -9.14%
2015 17.86%

STE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full STE Dividend History

Continue Researching STE

Here are a few links from around the web to help you further your research on STERIS plc's stock as an investment opportunity:

STERIS plc (STE) Stock Price | Nasdaq
STERIS plc (STE) Stock Quote, History and News - Yahoo Finance
STERIS plc (STE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7745 seconds.